Where the scripts are, who writes them, and what the market already pays for.
Part D prescriber and geographic spending, Medicaid state drug utilization, CDC disease prevalence, clinical trial activity, and FDA adverse event reporting for the market you name.
Why this market needs sourced data
Launch and market-access teams buy expensive claims panels for signals that the federal record already publishes at prescriber and state grain.
RepVector assembles the free record first, prices the gaps honestly, and shows exactly which questions the public data can and cannot answer.
What you get, with examples
Named prescriber volume by drug
Part D prescriber files give claim counts and cost per clinician per drug — the core of a targeting file.
Example
Top prescribers of a therapeutic class in a state, with practice location for territory assignment.
Medicaid channel visibility
State drug utilization data shows quarterly product-level Medicaid volume, often the launch channel that decides viability.
Example
Compare Medicaid units for a competitor product across four states over eight quarters.
Burden and trial context
PLACES prevalence and active clinical trial sites indicate where disease burden and investigator relationships concentrate.
Example
Map counties with high prevalence and an active trial site within 50 miles.
Safety-signal awareness
openFDA adverse event reporting gives a public read on class-level safety chatter.
Example
Pull adverse event counts for a competitor molecule before a field message update.
Questions you can ask
Who are the top prescribers of this drug class in the state?
How is Medicaid utilization trending for the competitor product?
Where is prevalence highest relative to prescriber supply?
Which trial sites are active for this condition nearby?
Datasets this question usually reaches for
Selection happens at runtime against your question and geography — this list is typical, not fixed. Anything a source cannot cover at your grain is reported as a gap.
Topics this page covers
- prescriber targeting by drug class
- Medicare Part D prescriber volume data
- Medicaid state drug utilization analysis
- pharma launch market sizing by county
- clinical trial site mapping
Related solutions
Physician practices and groups
Identify and rank physician practices and named clinicians by specialty, Medicare service volume, prescribing and location for any market, with exclusion screening.
Read morePayers and managed care
Medicare Advantage penetration, Medicaid enrollment, payer mix of hospital stays, spending variation and provider supply for payer strategy and network planning.
Read moreDiagnostics, labs and imaging
Order-volume signals, facility inventory, referring clinician ranking and disease burden for lab and imaging growth in any county or state.
Read moreBuild the pharma and market access list for one county and check the names yourself.
Three runs free. Every row carries its source, vintage and rank reason. See pricing.